Swiss researchers at ETH Zurich have developed an experimental implantable device that could help control blood sugar levels without insulin by using electricity to convert excess glucose into a substance that the body can eliminate.
The device converts excess glucose in the blood into gluconate, which is removed through the kidneys and expelled in urine. The technology could open a new research avenue for treating diabetes and obesity, although it has not yet been tested in humans.
The wireless-powered device is connected to a continuous glucose monitoring system, allowing it to respond to changes in blood sugar levels. In experiments involving mice, researchers found that the system could automatically regulate glucose levels.
The study also found that the device increased the use of stored body fat, raising the possibility that the technology could eventually help address both diabetes and obesity.
However, the device remains experimental. Its safety and effectiveness in humans have not been established, and further research and clinical trials are required before it could be considered for medical use.